Moto G5 Plus was launched in February 2017. Moto G5 Plus expected to launch in March in India. Moto G5 Plus features a 5.2-inch full HD LCD display with 1920 x 1080 pixel resolution (424 ppi pixel ...

Ithaka US Growth Strategy highlighted stocks like DexCom, Inc. (NASDAQ:DXCM), in the second quarter 2024 investor letter. DexCom, Inc. (NASDAQ:DXCM) is a medical device company engages in the ...

4. Who switched off the mobile transmitter tower near the crash site, and what happened to the passengers’ phones? 5. Who sanctioned the movement of the aircraft wreckage from the crash site, and why?

Medical device specialist DexCom (NASDAQ: DXCM) is going through a rough patch. The company's shares dropped off a cliff following its second-quarter earnings report. However, zooming out helps ...

DexCom is one of the leaders in an industry with massive growth potential. The company is building a competitive advantage. Despite several risks, it could deliver substantial returns in the long ...

T-Mobile is the third-largest wireless carrier in the United States, with its popularity largely down to its network coverage and the wide range of tempting offers available. They span from T ...

San Diego’s Dexcom began sales this week of Stelo, the industry’s first FDA-approved continuous glucose monitor that doesn’t require a prescription. With a two-pack of the biosensor costing ...

A tiny streaming box tapping into the power of Android, the Fetch Mini Gen 5 (G5) puts the best of broadcast and internet video at your fingertips. For Australians who don’t want to hand over their ...

We first reported on Stelo at CES 2024, and 8 months on, it’s now available in the US without a prescription. Unlike the company’s existing G7 CGM, Stelo is designed for adults 18+ who are not ...

Stelo is a small biosensor worn on the back of the upper arm that leverages Dexcom's most accurate glucose sensing technology. 5 It is specifically designed to provide the 125 million Americans 6 with ...

Aug 26 (Reuters) - Dexcom (DXCM.O), opens new tab said on Monday its over-the-counter continuous glucose monitor, Stelo, is now available for use in the United States at a price of up to $99.